Introduction and cause of death - CAA - Home

This guidance includes information about LAI antipsychotic medications which are currently licensed in the UK (that is: Xeplion®, Trevicta®, Abilify Maintena®, Risperdal Consta®, Zypadhera®). The guidance may not be accurate for different formulations of the medications. ................
................